{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:00:27Z","timestamp":1770433227830,"version":"3.49.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":5643,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1111\/j.1538-7836.2007.02501.x","type":"journal-article","created":{"date-parts":[[2007,7,9]],"date-time":"2007-07-09T11:57:52Z","timestamp":1183982272000},"page":"276-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"S1","title":["Thrombophilia and pregnancy complications: cause or association?"],"prefix":"10.1016","volume":"5","author":[{"given":"S.","family":"MIDDELDORP","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0010","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0015","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0038-1650282","article-title":"The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women","volume":"75","author":"Sanson","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0020","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(96)04125-6","article-title":"Increased fetal loss in women with heritable thrombophilia","volume":"348","author":"Preston","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0025","doi-asserted-by":"crossref","first-page":"736","DOI":"10.7326\/0003-4819-130-9-199905040-00013","article-title":"Increased risk for fetal loss in carriers of the factor V Leiden mutation","volume":"130","author":"Meinardi","year":"1999","journal-title":"Ann Int Med"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0030","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0140-6736(03)12771-7","article-title":"Thrombophilic disorders and fetal loss: a meta-analysis","volume":"361","author":"Rey","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.2005.05847.x","article-title":"Thrombophilia in pregnancy: a systematic review","volume":"132","author":"Robertson","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0040","first-page":"90S","article-title":"Current practice of testing for hereditary thrombophilia in The Netherlands","volume":"133","author":"Coppens","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0045","first-page":"516","article-title":"Inherited antithrombin III deficiency causing thrombophilia","volume":"13","author":"Egeberg","year":"1965","journal-title":"Thromb Diath Haemorrh"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0050","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI110385","article-title":"Deficiency of protein C in congenital thrombotic disease","volume":"68","author":"Griffin","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0055","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJM198412133112401","article-title":"Recurrent venous thromboembolism in patients with a partial deficiency of protein S","volume":"311","author":"Comp","year":"1984","journal-title":"N Eng J Med"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0060","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0065","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1073\/pnas.90.3.1004","article-title":"Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C","volume":"90","author":"Dahlback","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0070","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","article-title":"A common genetic variation in the 3\u2032-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis","volume":"88","author":"Poort","year":"1996","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0075","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1161\/01.ATV.14.7.1080","article-title":"High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis","volume":"14","author":"Falcon","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0080","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1055\/s-0037-1615380","article-title":"Hyperhomocysteinemia and venous thrombosis: a meta-analysis","volume":"80","author":"Den Heijer","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0085","doi-asserted-by":"crossref","first-page":"226","DOI":"10.7326\/0003-4819-145-3-200608010-00011","article-title":"Trials that matter: should we routinely measure homocysteine levels and \u201ctreat\u201d mild hyperhomocysteinemia?","volume":"145","author":"Rosenberg","year":"2006","journal-title":"Ann Int Med"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2006-04-014654","article-title":"Homocysteine lowering by B vitamins and the secondary prevention of deep-vein thrombosis and pulmonary embolism. A randomized, placebo-controlled, double blind trial","volume":"109","author":"Den Heijer","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0095","unstructured":"Lijfering W, Coppens M, Van Der Poel MH, Middeldorp S, Hamulyak K, Bank I, Veeger NJ, Prins MH, Buller HR, Van Der Meer J. The risk of venous and arterial thrombosis in hyperhomocysteinemia is low and mainly depends on concomitant thrombophilic defects. Thromb Haemost, in press."},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000065076","article-title":"Common C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of venous thromboembolism: meta-analysis of 31 studies","volume":"32","author":"Ray","year":"2002","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0105","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(95)90166-3","article-title":"Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis","volume":"345","author":"Koster","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0110","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1055\/s-0037-1614985","article-title":"Familial clustering of factor VIII and von Willebrand factor levels","volume":"79","author":"Kamphuisen","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0115","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1538-7836.2004.01033.x","article-title":"Elevated levels of FVIII:c within families are associated with an increased risk for venous and arterial thrombosis","volume":"3","author":"Bank","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0120","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1046\/j.1365-2141.2000.02091.x","article-title":"Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia","volume":"109","author":"Kamphuisen","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0125","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1093\/humrep\/dei167","article-title":"Updated and revised nomenclature for description of early pregnancy events","volume":"20","author":"Farquharson","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0130","doi-asserted-by":"crossref","first-page":"IX","DOI":"10.3109\/10641950109152635","article-title":"The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)","volume":"20","author":"Brown","year":"2001","journal-title":"Hypertens Pregnancy"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0135","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0002-9378(96)70162-X","article-title":"Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome","volume":"175","author":"Audibert","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0140","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/bmj.295.6605.1033","article-title":"Doctors and witchdoctors: which doctors are which?","volume":"295","author":"Briskman","year":"1987","journal-title":"I Br Med J (Clin Res Ed)"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0145","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1136\/bmj.295.6606.1108","article-title":"Doctors and witchdoctors: which doctors are which?\u2013II","volume":"295","author":"Briskman","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0150","first-page":"295","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc R Soc Med"},{"issue":"Suppl. 1","key":"10.1111\/j.1538-7836.2007.02501.x_bb0155","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.2105\/AJPH.2004.059204","article-title":"Causation and causal inference in epidemiology","volume":"95","author":"Rothman","year":"2005","journal-title":"Am J Public Health"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0160","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0140-6736(06)69204-0","article-title":"Recurrent miscarriage","volume":"368","author":"Rai","year":"2006","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0165","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(98)10266-0","article-title":"Venous thrombosis: a multicausal disease","volume":"353","author":"Rosendaal","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0170","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/jech.2002.006361","article-title":"A definition of causal effect for epidemiological research","volume":"58","author":"Hernan","year":"2004","journal-title":"J Epidemiol Community Health"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0175","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/ije\/dyh132","article-title":"Mendelian randomization: prospects, potentials, and limitations","volume":"33","author":"Smith","year":"2004","journal-title":"Int J Epidemiol"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0180","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(04)16261-2","article-title":"When are observational studies as credible as randomized trials?","volume":"363","author":"Vandenbroucke","year":"2004","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0185","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0190","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: assessing the quality of controlled clinical trials","volume":"323","author":"Juni","year":"2000","journal-title":"BMJ"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0195","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1001\/archinte.164.17.1932","article-title":"Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study","volume":"164","author":"Bank","year":"2004","journal-title":"Arch Int Med"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0200","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1160\/TH04-03-0198","article-title":"Unselected women with elevated levels of factor VIII:c or homocysteine are not at increased risk for obstetric complications","volume":"92","author":"Middeldorp","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0205","first-page":"2214","article-title":"Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a meta-analysis","volume":"33","author":"Opatrny","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0210","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1053\/beog.2000.0124","article-title":"Genetic aspects of miscarriage","volume":"14","author":"Goddijn","year":"2000","journal-title":"Baillieres Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0215","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1093\/humrep\/del150","article-title":"Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage","volume":"21","author":"Jauniaux","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0220","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1055\/s-0037-1613083","article-title":"Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review","volume":"87","author":"Morrison","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0225","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/j.1538-7836.2005.01417.x","article-title":"Thrombophilia and pregnancy outcomes","volume":"3","author":"Pabinger","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0230","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1191\/0961203302lu266oa","article-title":"Biology and pathology of the placenta in relation to antiphospholipid antibody-associated pregnancy failure","volume":"11","author":"Sebire","year":"2002","journal-title":"Lupus"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0235","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.fertnstert.2004.07.978","article-title":"Antiphospholipid antibodies prevent extravillous trophoblast differentiation","volume":"83","author":"Quenby","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0240","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ajog.2004.09.029","article-title":"Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure","volume":"192","author":"Bose","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0245","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nm825","article-title":"The thrombomodulin-protein C system is essential for the maintenance of pregnancy","volume":"9","author":"Isermann","year":"2003","journal-title":"Nat Med"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0250","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)","volume":"314","author":"Rai","year":"1997","journal-title":"BMJ"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0255","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00006250-200212000-00032","article-title":"Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment","volume":"100","author":"Farquharson","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0260","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.fertnstert.2004.11.002","article-title":"Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin vs. unfractionated heparin","volume":"83","author":"Noble","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0265","doi-asserted-by":"crossref","unstructured":"Empson M, Lassere M, Craig JC, Scott JR. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 2005, Issue 2. Art. No.: CD 002859. DOI: 10.1002\/14651858.CD002859.pub2.","DOI":"10.1002\/14651858.CD002859.pub2"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0270","doi-asserted-by":"crossref","first-page":"627S","DOI":"10.1378\/chest.126.3_suppl.627S","article-title":"Use of antithrombotic agents during pregnancy. The seventh ACCP conference on antithrombotic and thrombolytic therapy","volume":"126","author":"Bates","year":"2004","journal-title":"Chest"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0275","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1046\/j.1538-7836.2003.00504.x","article-title":"Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications \u2013 yes","volume":"1","author":"Brenner","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0280","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1538-7836.2004.01130.x","article-title":"The long and winding road towards LMWH for pregnancy loss","volume":"3","author":"Gris","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0285","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1046\/j.1538-7836.2003.00503.x","article-title":"Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications \u2013 no","volume":"1","author":"Middeldorp","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0290","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1538-7836.2005.01155.x","article-title":"Low molecular weight heparin for repeated pregnancy loss \u2013 is it based on solid evidence?","volume":"3","author":"Lindqvist","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0295","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1055\/s-0037-1613894","article-title":"Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin","volume":"83","author":"Brenner","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0300","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/10641950109152640","article-title":"Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias","volume":"20","author":"Kupferminc","year":"2001","journal-title":"Hypertens Pregnancy"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0305","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0015-0282(02)03222-3","article-title":"Preventing adverse obstetric outcomes in women with genetic thrombophilia","volume":"78","author":"Grandone","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0310","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0301-2115(98)00083-9","article-title":"Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study","volume":"80","author":"Riyazi","year":"1998","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0315","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1538-7836.2003.00066.x","article-title":"Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia","volume":"1","author":"Carp","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0320","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1538-7836.2004.00662.x","article-title":"Hereditary thrombophilia and fetal loss: a prospective follow-up study","volume":"2","author":"Vossen","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0325","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1365-2141.2006.06480.x","article-title":"Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women","volume":"136","author":"Folkeringa","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0330","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/humrep\/17.2.442","article-title":"Factor V Leiden and recurrent miscarriage-prospective outcome of untreated pregnancies","volume":"17","author":"Rai","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0335","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1538-7836.2006.01839.x","article-title":"The natural course of women with recurrent fetal loss","volume":"4","author":"Lindqvist","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0340","unstructured":"Coppens M, Folkeringa N, Teune M, Hamulyak K, Van Der Meer J, Prins MH, et\u00a0al. Natural course of the subsequent pregnancy after a single loss in women with and without the factor V Leiden or prothrombin 20210A mutations. J Thromb Haemost, in press."},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0345","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0002-9378(84)80164-7","article-title":"Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion","volume":"148","author":"Stray-Pedersen","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0350","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/blood-2003-12-4250","article-title":"Low-molecular-weight heparin vs. low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder","volume":"103","author":"Gris","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0355","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1182\/blood-2004-06-2121","article-title":"Important publication missing key information","volume":"104","author":"Rodger","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0360","first-page":"3413","article-title":"Response: thromboprophylaxis for first fetal loss","volume":"104","author":"Gris","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0365","series-title":"Cochrane Database Syst Rev","article-title":"Anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome","author":"DiNisio","year":"2005"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0370","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1538-7836.2004.01090.x","article-title":"Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study","volume":"3","author":"Brenner","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0375","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1538-7836.2005.01288.x","article-title":"The use of LMWH in pregnancies at risk: new evidence or perception?","volume":"3","author":"Middeldorp","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02501.x_bb0380","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0015-0282(00)01595-8","article-title":"Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis","volume":"74","author":"Nelen","year":"2000","journal-title":"Fertil Steril"}],"updated-by":[{"DOI":"10.1111\/j.1538-7836.2007.02703_1.x","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000}}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2007.02501.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622175914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622175914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2007.02501.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:46:18Z","timestamp":1761533178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622175914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":75,"alternative-id":["S1538783622175914"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02501.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombophilia and pregnancy complications: cause or association?","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02501.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}